Alvotech to participate in upcoming jefferies london healthcare conference in november

Reykjavik, iceland , oct. 26, 2022 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that members of the leadership team will participate in the jefferies london healthcare conference from november 15th to november 17th.
ALVO Ratings Summary
ALVO Quant Ranking